Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study

导出原文传递

翻译打印收藏纠错

作者： Meredith,Castro ^[1] ; Samuel T.,Wilkinson ^[2] ; Rayan K.,Al Jurdi ^[3] ; Mary Pat,Petrillo ^[4] ; Naim,Zaki ^[5] ; Stephane,Borentain ; Dong Jing,Fu ; Ibrahim,Turkoz ; Liping,Sun ; Brianne,Brown ; Patricia,Cabrera

作者单位： The Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine ^[1] Janssen Scientific Affairs, LLC ^[2] Janssen Research & Development, LLC ^[3] Cytel ^[4] Department of Psychiatry, School of Medicine,Yale University ^[5]

发布时间 2023-10-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

CNS drugs

2023年37卷8期

715-723页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study

CNS drugs

相似文献

CNS drugs

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study

CNS drugs

相似文献

CNS drugs

相关期刊

检索历史清除